chloramphenicol has been researched along with Paraproteinemias in 4 studies
Amphenicol: Chloramphenicol and its derivatives.
Paraproteinemias: A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraunfelder, FW | 2 |
| Fraunfelder, FT | 2 |
| Buckley, RJ | 1 |
| Kirkness, CM | 1 |
| Kanski, JJ | 1 |
| Ridgway, AE | 1 |
| Tullo, AB | 1 |
| Watson, PG | 1 |
| Besamusca, FW | 1 |
| Bastiaensen, LA | 1 |
4 other studies available for chloramphenicol and Paraproteinemias
| Article | Year |
|---|---|
Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact?
Topics: Administration, Topical; Adverse Drug Reaction Reporting Systems; Anemia, Aplastic; Anti-Bacterial A | 2013 |
Scientific challenges in postmarketing surveillance of ocular adverse drug reactions.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Chloramphenicol; Databases, Factual; Drug-Relat | 2007 |
Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasia.
Topics: Chloramphenicol; Contraindications; Humans; Ophthalmic Solutions; Paraproteinemias | 1995 |
Blood dyscrasias and topically applied chloramphenicol in ophthalmology.
Topics: Administration, Topical; Anemia, Aplastic; Bone Marrow; Chloramphenicol; Humans; Paraproteinemias; P | 1986 |